Zimmer Biomet Announces Fourth Quarter and Full-Year 2025 Financial Results Feb 10, 2026 06:30AM
Zimmer Biomet Announces Third Quarter 2025 Financial Results Nov 5, 2025 06:30AM
Zimmer Biomet receives Japan approval for iodine-treated hip implants Sep 25, 2025 04:30PM
Zimmer Biomet Announces Japan PMDA Approval of World's First Iodine-Treated Total Hip Replacement System Sep 25, 2025 04:30PM
Zimmer Biomet to Showcase Foot and Ankle Portfolio at the American Orthopedic Foot and Ankle Society Annual Conference Sep 4, 2025 04:05PM
View Older Stories

Aug 28, 2025 07:31AM Zimmer Biomet names two new chief medical advisors
Aug 28, 2025 07:30AM Zimmer Biomet Announces New Chief Medical Advisors to Help Improve Standard of Musculoskeletal Care
Aug 27, 2025 07:00AM Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2025
Aug 25, 2025 07:30AM Zimmer Biomet to Present at the Annual Morgan Stanley Healthcare Conference
Aug 7, 2025 06:30AM Zimmer Biomet Announces Second Quarter 2025 Financial Results
Jul 14, 2025 07:30AM Zimmer Biomet to acquire Monogram Technologies for $177 million
Jul 14, 2025 07:30AM Zimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous Solutions
Jul 9, 2025 07:30AM Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2025 Financial Results
May 30, 2025 07:00AM Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2025
May 27, 2025 07:34AM Zimmer Biomet Holdings (ZBH) Appoints Kevin Thornal as Group President, Global Businesses and the Americas
May 27, 2025 07:30AM Zimmer Biomet Appoints Kevin Thornal as Group President, Global Businesses and the Americas
May 22, 2025 07:30AM Zimmer Biomet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
May 5, 2025 06:30AM Zimmer Biomet Announces First Quarter 2025 Financial Results
Apr 21, 2025 09:00AM Zimmer Biomet Completes Acquisition of Paragon 28
Apr 10, 2025 07:30AM Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2025 Financial Results
Apr 1, 2025 07:30AM Zimmer Biomet Receives CE Mark Approval for RibFix Advantage® Fixation System
Mar 10, 2025 07:30AM Zimmer Biomet Highlights Diverse Portfolio of Orthopedic & Musculoskeletal Innovations at AAOS 2025 Annual Meeting
Mar 7, 2025 07:30AM Zimmer Biomet Holdings (ZBH) Receives FDA Clearance for Persona Revision SoluTion Femur
Mar 7, 2025 07:30AM Zimmer Biomet Receives FDA Clearance for Persona® Revision SoluTion™ Femur
Mar 6, 2025 07:31AM Zimmer Biomet Holdings (ZBH) Appoints Kristen Cardillo as SVP, Chief Communications Officer
Mar 6, 2025 07:30AM Zimmer Biomet Names Kristen Cardillo as Senior Vice President, Chief Communications Officer
Feb 28, 2025 07:30AM Zimmer Biomet to Present at the 27th Annual Barclays Healthcare Conference
Feb 27, 2025 07:30AM Zimmer Biomet Holdings (ZBH) Appoints Jehanzeb Noor as Senior Vice President, Chief Strategy, Innovation and Business Development Officer
Feb 27, 2025 07:30AM Zimmer Biomet Appoints Jehanzeb Noor as Senior Vice President, Chief Strategy, Innovation and Business Development Officer
Feb 26, 2025 07:30AM Zimmer Biomet Launches You'll Be Back Campaign with Chief Movement Officer Arnold Schwarzenegger
Feb 26, 2025 07:00AM Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2025
Feb 25, 2025 04:08PM Zimmer Biomet Holdings (ZBH) Announces Board Changes
Feb 25, 2025 04:05PM Zimmer Biomet Announces Upcoming Changes to Company's Board of Directors
Feb 6, 2025 06:30AM Zimmer Biomet Announces Fourth Quarter and Full-Year 2024 Financial Results
Jan 28, 2025 06:33PM Zimmer Biomet Holdings (ZBH) to Acquire Paragon 28 for $1.1 bln
Jan 28, 2025 05:59PM Zimmer Biomet Announces Definitive Agreement to Acquire Paragon 28
Jan 16, 2025 07:30AM Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2024 Financial Results
Dec 20, 2024 07:30AM Zimmer Biomet to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Dec 18, 2024 07:00AM Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2024
Dec 13, 2024 07:30AM Zimmer Biomet Holdings (ZBH) Receives FDA Clearance for OsseoFit Stemless Shoulder System for Total Shoulder Replacement
Dec 13, 2024 07:30AM Zimmer Biomet Receives FDA Clearance for OsseoFit™ Stemless Shoulder System for Total Shoulder Replacement
Dec 4, 2024 07:30AM Zimmer Biomet Holdings (ZBH) Receives FDA Clearance for Persona SoluTion PPS® Femur
Dec 4, 2024 07:30AM Zimmer Biomet Receives FDA Clearance for Persona® SoluTion™ PPS® Femur
Nov 25, 2024 04:21PM Zimmer Biomet Holdings (ZBH) Receives FDA Approval for Oxford Cementless Partial Knee, Only Cementless Partial Knee Replacement Implant in the U.S.
Nov 25, 2024 04:05PM Zimmer Biomet Receives FDA Approval for Oxford® Cementless Partial Knee, Only Cementless Partial Knee Replacement Implant in the U.S.
Nov 21, 2024 07:30AM Zimmer Biomet to Present at Citi's 2024 Global Healthcare Conference
Nov 18, 2024 07:31AM Zimmer Biomet (ZBH) Announces CE Mark Certification for Persona® Revision Knee System
Nov 18, 2024 07:30AM Zimmer Biomet Announces CE Mark Certification for Persona® Revision Knee System
Nov 13, 2024 07:31AM Zimmer Biomet Holdings (ZBH) Appoints Arnold Schwarzenegger as Chief Movement Officer
Nov 13, 2024 07:30AM Zimmer Biomet Welcomes Arnold Schwarzenegger as Chief Movement Officer
Nov 7, 2024 07:30AM Zimmer Biomet to Present at Jefferies London Healthcare Conference
Oct 30, 2024 06:30AM Zimmer Biomet Announces Third Quarter 2024 Financial Results
Oct 28, 2024 07:31AM Zimmer Biomet Holdings (ZBH) to Debut New Z1 Femoral Hip System and Clinical Data on G7® Acetabular System at 2024 AAHKS Annual Meeting
Oct 28, 2024 07:30AM Zimmer Biomet to Debut New Z1™ Femoral Hip System and Clinical Data on G7® Acetabular System at 2024 AAHKS Annual Meeting
Oct 9, 2024 07:30AM Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2024 Financial Results
View Older Stories